Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

252 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ampicillin/sulbactam in elderly patients with community-acquired pneumonia.
Majcher-Peszynska J, Loebermann M, Klammt S, Frimmel S, Mundkowski RG, Welte T, Reisinger EC, Drewelow B; CAPNETZ Study Group. Majcher-Peszynska J, et al. Among authors: reisinger ec. Infection. 2014 Feb;42(1):79-87. doi: 10.1007/s15010-013-0518-8. Epub 2013 Aug 1. Infection. 2014. PMID: 23904004
Multiple sclerosis treatment and infectious issues: update 2013.
Winkelmann A, Loebermann M, Reisinger EC, Zettl UK. Winkelmann A, et al. Among authors: reisinger ec. Clin Exp Immunol. 2014 Mar;175(3):425-38. doi: 10.1111/cei.12226. Clin Exp Immunol. 2014. PMID: 24134716 Free PMC article. Review.
Safety and immunogenicity of a trivalent single dose seasonal influenza vaccine containing pandemic A(H1N1) antigen in younger and elderly subjects: a phase III open-label single-arm study.
Loebermann M, Anders G, Brestrich G, Fritzsche C, Klammt S, Boršo D, Frimmel S, Riebold D, Reisinger EC. Loebermann M, et al. Among authors: reisinger ec. Vaccine. 2011 Feb 1;29(6):1228-34. doi: 10.1016/j.vaccine.2010.11.092. Epub 2010 Dec 15. Vaccine. 2011. PMID: 21167116 Clinical Trial.
A phase III, open-label, single-arm, study to evaluate the safety and immunogenicity of a trivalent, surface antigen inactivated subunit influenza virus vaccine produced in mammalian cell culture (Optaflu®) in healthy adults.
Loebermann M, Fritzsche C, Geerdes-Fenge H, Heijnen E, Kirby D, Reisinger EC. Loebermann M, et al. Among authors: reisinger ec. Infection. 2019 Feb;47(1):105-109. doi: 10.1007/s15010-018-1233-2. Epub 2018 Oct 8. Infection. 2019. PMID: 30298473 Clinical Trial.
Bilateral upper arm swelling and weight loss.
Fritzsche C, Loebermann M, Reisinger EC. Fritzsche C, et al. Among authors: reisinger ec. Gastroenterology. 2011 Nov;141(5):1564, 1950-1. doi: 10.1053/j.gastro.2010.09.011. Epub 2011 Sep 28. Gastroenterology. 2011. PMID: 21963796 No abstract available.
Vaccination against infection in patients with multiple sclerosis.
Loebermann M, Winkelmann A, Hartung HP, Hengel H, Reisinger EC, Zettl UK. Loebermann M, et al. Among authors: reisinger ec. Nat Rev Neurol. 2012 Jan 24;8(3):143-51. doi: 10.1038/nrneurol.2012.8. Nat Rev Neurol. 2012. PMID: 22270022 Review.
Clinical trial to evaluate the safety and immunogenicity of a trivalent surface antigen seasonal influenza vaccine produced in mammalian cell culture and administered to young and elderly adults with and without A(H1N1) pre-vaccination.
Loebermann M, Voss U, Meyer S, Bosse D, Fritzsche C, Klammt S, Frimmel S, Riebold D, Reisinger EC. Loebermann M, et al. Among authors: reisinger ec. PLoS One. 2013 Aug 16;8(8):e70866. doi: 10.1371/journal.pone.0070866. eCollection 2013. PLoS One. 2013. PMID: 23976960 Free PMC article. Clinical Trial.
252 results